X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (866) 866
Book Review (418) 418
Publication (58) 58
Book Chapter (17) 17
Book / eBook (15) 15
Conference Proceeding (3) 3
Magazine Article (2) 2
Dissertation (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (650) 650
humans (569) 569
immunology (302) 302
allergy (259) 259
dermatology (237) 237
asthma (218) 218
double-blind (183) 183
female (181) 181
male (179) 179
severe atopic-dermatitis (166) 166
animals (164) 164
psoriasis (145) 145
atopic dermatitis (140) 140
severe asthma (135) 135
adult (119) 119
inflammation (109) 109
skin (107) 107
child (97) 97
middle aged (93) 93
atopic-dermatitis (92) 92
cytokines (90) 90
abridged index medicus (87) 87
placebo-controlled trial (85) 85
children (84) 84
quality-of-life (84) 84
allergies (76) 76
treatment outcome (76) 76
care and treatment (75) 75
pharmacology & pharmacy (75) 75
analysis (74) 74
asthma - drug therapy (73) 73
severe plaque psoriasis (73) 73
allergy and immunology (72) 72
adolescent (71) 71
disease (70) 70
drug therapy (69) 69
efficacy (69) 69
omalizumab (69) 69
severity of illness index (69) 69
medicine & public health (67) 67
immunoglobulin e (65) 65
internal medicine (65) 65
t cells (63) 63
dermatitis (62) 62
antibodies, monoclonal - therapeutic use (61) 61
patients (61) 61
severe combined immunodeficiency (61) 61
health aspects (60) 60
quality of life (59) 59
research (59) 59
clinical trials (57) 57
pediatrics (57) 57
asthma - immunology (56) 56
monoclonal-antibody (56) 56
psoriasis - drug therapy (55) 55
review (54) 54
to-severe psoriasis (54) 54
safety (53) 53
moderate (52) 52
skin diseases (52) 52
therapy (52) 52
severe persistent asthma (51) 51
aged (50) 50
child, preschool (50) 50
medical research (50) 50
dermatitis, atopic - drug therapy (49) 49
monoclonal antibodies (49) 49
phenotype (49) 49
ige (47) 47
immunosuppressive agents - therapeutic use (47) 47
biomarkers (46) 46
eczema (43) 43
infant (43) 43
studies (43) 43
expression (42) 42
immunotherapy (42) 42
lymphocytes (42) 42
risk factors (42) 42
genetic aspects (40) 40
hypersensitivity - immunology (40) 40
immunoglobulin e - immunology (40) 40
inhaled corticosteroids (40) 40
mice (40) 40
severe allergic-asthma (40) 40
severe eosinophilic asthma (40) 40
young adult (40) 40
necrosis-factor-alpha (39) 39
anti-asthmatic agents - therapeutic use (38) 38
dendritic cells (38) 38
rheumatoid-arthritis (37) 37
randomized controlled-trial (36) 36
t-cells (36) 36
allergens (35) 35
diagnosis (35) 35
medical colleges (35) 35
medicine, research & experimental (35) 35
proteins (35) 35
respiratory system (35) 35
severe psoriasis (35) 35
skin diseases - drug therapy (35) 35
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (13) 13
Scarborough Hospital - General (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Humber River Regional Hospital - Keele Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Toronto East General Hospital - Reference (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (854) 854
French (10) 10
German (10) 10
Japanese (9) 9
Polish (7) 7
Spanish (4) 4
Korean (3) 3
Dutch (1) 1
Portuguese (1) 1
Russian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2005, Volume 53, Issue 2, pp. 338 - 340
Journal Article
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 137, Issue 5, pp. 1347 - 1358
Journal Article
Monaldi Archives for Chest Disease - Pulmonary Series, ISSN 1122-0643, 2008, Volume 69, Issue 2, pp. 78 - 80
Journal Article
Journal of Investigational Allergology and Clinical Immunology, ISSN 1018-9068, 2019, Volume 29, Issue 1, pp. 77 - 79
Journal Article
Journal of Investigational Allergology and Clinical Immunology, ISSN 1018-9068, 2018, Volume 28, Issue 3, pp. 195 - 197
Journal Article
JOURNAL OF INVESTIGATIVE DERMATOLOGY, ISSN 0022-202X, 05/2019, Volume 139, Issue 5, pp. 1063 - 1072
A phase 2, double-blind, placebo-controlled trial evaluated apremilast efficacy, safety, and pharmacodynamics in adults with moderate to severe atopic... 
MODERATE | PHOSPHODIESTERASE-4 PDE4 INHIBITOR | MANAGEMENT | EFFICACY | SAFETY | TOLERABILITY | SEVERE PLAQUE PSORIASIS | GUIDELINES | SKIN | CARE | DERMATOLOGY
Journal Article
JAAD Case Reports, ISSN 2352-5126, 01/2015, Volume 1, Issue 1, pp. 25 - 26
Journal Article
Journal of Dermatological Science, ISSN 0923-1811, 05/2019, Volume 94, Issue 2, pp. 266 - 275
Two phase 3 trials with identical design, LIBERTY AD SOLO 1 (NCT02277743) and LIBERTY AD SOLO 2 (NCT02277769), confirmed dupilumab efficacy and safety versus... 
Efficacy | Adults | Moderate-to-severe atopic dermatitis | Safety | Pooled analysis | Dupilumab | PLACEBO | CLINICAL-TRIAL | PERSISTENT ASTHMA | DERMATOLOGY | VIRAL-INFECTIONS | PATIENT BURDEN | DISEASE | ECZEMA HERPETICUM | QUALITY-OF-LIFE | HEALTH | SKIN | Atopic dermatitis | Analysis
Journal Article
Skin Research, ISSN 1347-1813, 12/2014, Volume 13, pp. 11 - 14
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 05/2008, Volume 128, Issue 5, pp. 1173 - 1181
Journal Article
ALLERGOLOGIE, ISSN 0344-5062, 03/2015, Volume 38, Issue 3, pp. 153 - 162
Psoriasis vulgaris and atopic eczema are two T-cell-mediated chronic inflammatory skin diseases which often represent a therapeutic challenge in daily practice... 
treatment | MODERATE | biologics | EFFICACY | ANTI-CD20 RITUXIMAB TREATMENT | SAFETY | atopic dermatitis | PHASE-II | OPEN-LABEL | ANTI-IGE THERAPY | ALLERGY | psoriasis | SEVERE PLAQUE PSORIASIS | DOUBLE-BLIND | DOSE INTRAVENOUS IMMUNOGLOBULIN
Journal Article
European Journal of Medical Research, ISSN 0949-2321, 09/2011, Volume 16, Issue 9, pp. 407 - 410
Objective: Anti IgE treatment with omalizumab is efficacious in the treatment of patients suffering from allergic asthma, improving asthma control and... 
Omalizumab | Allergic asthma | Anti-IgE | Atopic dermatitis | Quality of life | MEDICINE, RESEARCH & EXPERIMENTAL | anti-IgE |